Ora Biomedical, Inc. is a Seattle-based pharmaceutical startup in the longevity biotechnology sector, focused on discovering and commercializing the most effective interventions targeting biological aging and age-related diseases. Founded in 2022 from Matt Kaeberlein’s Lab at the University of Washington School of Medicine, the company is committed to harnessing the potential of healthy aging therapeutics. Ora Biomedical aims to develop a new generation of broad-use small molecule interventions to promote healthy aging in humans, companion animals, and other organisms where extended healthy survival is desired.